Key result
CPT1b deficiency worsens pressure overload-induced cardiac hypertrophy by promoting lipotoxicity.
Why the study?
CPT1b deficiency can cause lipotoxicity in the heart under pathological stress, leading to exacerbation of cardiac pathology.
Does CPT1b deficiency aggravate pressure overload-induced cardiac hypertrophy?
Does CPT1b deficiency aggravate pressure overload-induced cardiac hypertrophy?
CPT1b deficiency exacerbates cardiac hypertrophy under pressure overload via lipotoxicity, suggesting caution with the clinical use of CPT1 inhibitors.
CPT1b deficiency can cause lipotoxicity in the heart under pathological stress, leading to exacerbation of cardiac pathology. Therefore, caution should be exercised in the clinical use of CPT1 inhibitors.
No takes yet. Share an insight, caveat, or question.
He et al. (2012) studied this question. Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy by causing lipotoxicity under pathological stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: